The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
DNA repair mechanisms in cancer development and therapy
Open accessAbstract
DNA damage has been long recognized as causal factor for cancer development. When erroneous DNA repair leads to mutations or chromosomal aberrations affecting oncogenes and tumor suppressor genes, cells undergo malignant transformation resulting in cancerous growth. Genetic defects can predispose to cancer: mutations in distinct DNA repair systems elevate the susceptibility to various cancer types. However, DNA damage not only comprises a root cause for cancer development but also continues to provide an important avenue for chemo- and radiotherapy. Since the beginning of cancer therapy, genotoxic agents that trigger DNA damage checkpoints have been applied to halt the growth and trigger the apoptotic demise of cancer cells. We provide an overview about the involvement of DNA repair systems in cancer prevention and the classes of genotoxins that are commonly used for the treatment of cancer. A better understanding of the roles and interactions of the highly complex DNA repair machineries will lead to important improvements in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Moser, J., Kool, H., Giakzidis, I., Caldecott, K., Mullenders, L. H. F., & Fousteri, M. I. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.014 · Cited by 261
RetractedRadiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Cancer and Radiation Therapy: Current Advances and Future Directions
Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K.-W. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.3635 · Cited by 2,880
Molecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760 · cited 2×
“The mono aquated form of cisplatin is the most reactive one, it can reactwithmany cytoplasmic nucleophiles substrates including reduced glutathione (GSH), methionine and metallothioneins (MT) but its cytotoxic effect comes from the capacity to target DNA (Galluzzi et al., 2011).”
BackgroundSensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
ATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Defective repair replication of DNA in xeroderma pigmentosum
CLEAVER, J. E. (1968) · Nature · doi:10.1038/218652a0 · Cited by 1,729
Delaney, G., Jacob, S., Featherstone, C., & Barton, M. (2005) · Cancer · doi:10.1002/cncr.21324 · Cited by 1,727
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Roy, R., Chun, J., & Powell, S. N. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3181 · Cited by 1,469
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
The multifaceted mismatch-repair system
Jiricny, J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1907 · Cited by 1,370
Radiobiology for the Radiologist
Fry, R. J. M., & Hall, E. J. (1995) · Radiation Research · doi:10.2307/3579017 · Cited by 1,337
McCabe, N., Turner, N. C., Lord, C. J., Kluzek, K., Białkowska, A., Swift, S., Giavara, S., O'Connor, M. J., Tutt, A. N., Zdzienicka, M. Z., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0140 · Cited by 1,310
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
Jordheim, L. P., Durantel, D., Zoulim, F., & Dumontet, C. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4010 · Cited by 1,211
Strategies to improve radiotherapy with targeted drugs
Begg, A. C., Stewart, F. A., & Vens, C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3007 · Cited by 1,118
The Bloom's syndrome helicase suppresses crossing over during homologous recombination
Wu, L., & Hickson, I. D. (2003) · Nature · doi:10.1038/nature02253 · Cited by 1,085
Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases
Kraemer, K. H. (1987) · Archives of Dermatology · doi:10.1001/archderm.123.2.241 · Cited by 1,068
Endogenous DNA damage in humans: a review of quantitative data
De Bont, R. (2004) · Mutagenesis · doi:10.1093/mutage/geh025 · Cited by 1,058
DNA repair dysregulation from cancer driver to therapeutic target
Curtin, N. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3399 · Cited by 1,051
Cyclophosphamide and cancer: golden anniversary
Emadi, A., Jones, R. J., & Brodsky, R. A. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.146 · Cited by 1,050
Transcription-coupled DNA repair: two decades of progress and surprises
Hanawalt, P. C., & Spivak, G. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2549 · Cited by 1,044
DNA interstrand crosslink repair and cancer
Deans, A. J., & West, S. C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3088 · Cited by 1,023
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Balancing repair and tolerance of DNA damage caused by alkylating agents
Fu, D., Calvo, J. A., & Samson, L. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3185 · Cited by 947
Schlacher, K., Wu, H., & Jasin, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.015 · Cited by 936
O'Driscoll, M., Ruiz-Perez, V. L., Woods, C. G., Jeggo, P. A., & Goodship, J. A. (2003) · Nature Genetics · doi:10.1038/ng1129 · Cited by 794
Direct Activation of the ATM Protein Kinase by the Mre11/Rad50/Nbs1 Complex
Lee, J.-H., & Paull, T. T. (2004) · Science · doi:10.1126/science.1091496 · Cited by 762
Lebwohl, D., & Canetta, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00224-x · Cited by 754
Gemcitabine: metabolism, mechanisms of action, and self-potentiation.
Plunkett, W. K., Huang, P., Xu, Y.-Z., Heinemann, V., Grunewald, R., & Gandhi, V. V. (1995) · PubMed · Cited by 753
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., Yang, M.-C. W., Hwang, L.-Y., Bowcock, A. M., & Baer, R. (1996) · Nature Genetics · doi:10.1038/ng1296-430 · Cited by 746
Biological Consequences of Radiation-induced DNA Damage: Relevance to Radiotherapy
Lomax, M. E., Folkes, L. K., & O'Neill, P. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.06.007 · Cited by 738
Purified human BRCA2 stimulates RAD51-mediated recombination
Jensen, R. B., Carreira, A., & Kowalczykowski, S. C. (2010) · Nature · doi:10.1038/nature09399 · Cited by 715
Repair of Endogenous DNA Damage
LINDAHL, T., & BARNES, D. E. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.127 · Cited by 714
Mechanism of homologous recombination: mediators and helicases take on regulatory functions
Sung, P., & Klein, H. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2008 · Cited by 700
Identification of the FANCI Protein, a Monoubiquitinated FANCD2 Paralog Required for DNA Repair
Smogorzewska, A., Matsuoka, S., Vinciguerra, P., McDonald, E. R., Hurov, K. E., Luo, J., Ballif, B. A., Gygi, S. P., Hofmann, K., D'Andrea, A. D., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.009 · Cited by 700
DNA repair mechanisms in dividing and non-dividing cells
Iyama, T., & Wilson, D. M. (2013) · DNA Repair · doi:10.1016/j.dnarep.2013.04.015 · Cited by 697
Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
Hertel, L. W., Boder, G. B., Kroin, J. S., Rinzel, S. M., Poore, G. A., Todd, G. C., & Grindey, G. B. (1990) · PubMed · Cited by 680
The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse
Hakem, R., de la Pompa, J. L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81302-1 · Cited by 667
Kaina, B., Christmann, M., Naumann, S., & Roos, W. P. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.03.008 · Cited by 663
DNA double-strand break repair: From mechanistic understanding to cancer treatment
HELLEDAY, T., LO, J., VANGENT, D., & ENGELWARD, B. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.02.006 · Cited by 640 · cited 2×
“Therefore, DNA damage not only causes tumor development but could also battle cancers by impairing cancer growth and ultimately triggering the death of malignant cells (Figure 1).”
BackgroundHuman and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA
Aas, P. A., Otterlei, M., Falnes, P. Ø., Vågbø, C. B., Skorpen, F., Akbari, M., Sundheim, O., Bjørås, M., Slupphaug, G., Seeberg, E., et al. (2003) · Nature · doi:10.1038/nature01363 · Cited by 638
Lehman, A. R., Kirk-Bell, S., Arlett, C. F., Paterson, M. C., Lohman, P. H., de Weerd-Kastelein, E. A., & Bootsma, D. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.1.219 · Cited by 614
Fanconi anaemia and the repair of Watson and Crick DNA crosslinks
Kottemann, M. C., & Smogorzewska, A. (2013) · Nature · doi:10.1038/nature11863 · Cited by 611
Nucleoside analogues and nucleobases in cancer treatment
Galmarini, C. M., Mackey, J. R., & Dumontet, C. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00788-x · Cited by 606
PARP is activated at stalled forks to mediate Mre11‐dependent replication restart and recombination
Bryant, H. E., Petermann, E., Schultz, N., Jemth, A., Loseva, O., Issaeva, N., Johansson, F., Fernandez, S., McGlynn, P., & Helleday, T. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.206 · Cited by 602
The role of DNA mismatch repair in platinum drug resistance.
Fink, D. A., Nebel, S., Aebi, S. P., Zheng, H., Cenni, B., Nehmé, A., Christen, R. D., & Howell, S. B. (1996) · PubMed · Cited by 597
The Deubiquitinating Enzyme USP1 Regulates the Fanconi Anemia Pathway
Nijman, S. M. B., Huang, T. T., Dirac, A. M. G., Brummelkamp, T. R., Kerkhoven, R. M., D'Andrea, A. D., & Bernards, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.008 · Cited by 588
UV-Induced Ubiquitylation of XPC Protein Mediated by UV-DDB-Ubiquitin Ligase Complex
Sugasawa, K., Okuda, Y., Saijo, M., Nishi, R., Matsuda, N., Chu, G., Mori, T., Iwai, S., Tanaka, K., Tanaka, K., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.035 · Cited by 576
Cellular and molecular pharmacology of oxaliplatin.
Raymond, É., Faivre, S. J., Chaney, S. G., WOYNAROWSKI, J. M., & Cvitkovic, E. (2002) · PubMed · Cited by 576
Cancer Risks and Mortality in Heterozygous ATM Mutation Carriers
Thompson, D., Duedal, S., Kirner, J., McGuffog, L., Last, J., Reiman, A., Byrd, P., Taylor, M., & Easton, D. F. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji141 · Cited by 543
Structure, Function, and Inhibition of O6-Alkylguanine-DNA Alkyltransferase
Pegg, A. E., Dolan, M. E., & Moschel, R. C. (1995) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60879-x · Cited by 506
Mechanism of open complex and dual incision formation by human nucleotide excision repair factors
Evans, E., Moggs, J. G., Hwang, J. R., Egly, J., & Wood, R. D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6559 · Cited by 500
BRCA1 and its toolbox for the maintenance of genome integrity
Huen, M. S. Y., Sy, S. M. H., & Chen, J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2831 · Cited by 490
DNA mismatch repair: Molecular mechanism, cancer, and ageing
Hsieh, P., & Yamane, K. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.02.012 · Cited by 464
S-phase–specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51
Taniguchi, T., Garcia-Higuera, I., Andreassen, P. R., Gregory, R. C., Grompe, M., & D'Andrea, A. D. (2002) · Blood · doi:10.1182/blood-2002-01-0278 · Cited by 461
Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice
de Klein, A., Muijtjens, M., van Os, R., Verhoeven, Y., Smit, B., Carr, A. M., Lehmann, A. R., & Hoeijmakers, J. H. J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00447-4 · Cited by 443
Cancer in xeroderma pigmentosum and related disorders of DNA repair
Cleaver, J. E. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1652 · Cited by 427
Wallace, S. S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00827-4 · Cited by 419
Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA
Liu, J., Doty, T., Gibson, B., & Heyer, W.-D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1904 · Cited by 401
Reconstitution of 5′-Directed Human Mismatch Repair in a Purified System
Zhang, Y., Yuan, F., Presnell, S. R., Tian, K., Gao, Y., Tomkinson, A. E., Gu, L., & Li, G.-M. (2005) · Cell · doi:10.1016/j.cell.2005.06.027 · Cited by 383
Koonin, E. V., Altschul, S. F., & Bork, P. (1996) · Nature Genetics · doi:10.1038/ng0796-266 · Cited by 368
Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains
Day, R. S., Ziolkowski, C. H. J., Scudiero, D. A., Meyer, S. A., Lubiniecki, A. S., Girardi, A. J., Galloway, S. M., & Bynum, G. D. (1980) · Nature · doi:10.1038/288724a0 · Cited by 366
Journal of Experimental Medicine
(2019) · The Journal of Experimental Medicine · doi:10.1084/jem · Cited by 366
Cisplatin resistance: Preclinical findings and clinical implications
Köberle, B., Tomicic, M. T., Usanova, S., & Kaina, B. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.07.004 · Cited by 361
Reardon, J. T., & Sancar, A. (2005) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(04)79004-2 · Cited by 350
de Laat, W. L., Appeldoorn, E., Sugasawa, K., Weterings, E., Jaspers, N. G. J., & Hoeijmakers, J. H. J. (1998) · Genes & Development · doi:10.1101/gad.12.16.2598 · Cited by 333
Park, G. Y., Wilson, J. J., Song, Y., & Lippard, S. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207670109 · Cited by 330
Genetic Heterogeneity of Xeroderma Pigmentosum demonstrated by Somatic Cell Hybridization
DE WEERD-KASTELEIN, E. A., KEIJZER, W., & BOOTSMA, D. (1972) · Nature New Biology · doi:10.1038/newbio238080a0 · Cited by 324
Holzer, A. K., Manorek, G. H., & Howell, S. B. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.022624 · Cited by 322
Venema, J., van Hoffen, A., Karcagi, V, Natarajan, A. T., van Zeeland, A. A., & Mullenders, L. H. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.8.4128 · Cited by 317
Overview of Base Excision Repair Biochemistry
Kim, Y.-J., & M. Wilson III, D. (2012) · Current Molecular Pharmacology · doi:10.2174/1874467211205010003 · Cited by 309
ATR-Chk2 Signaling in p53 Activation and DNA Damage Response during Cisplatin-induced Apoptosis
Pabla, N., Huang, S., Mi, Q.-S., Daniel, R., & Dong, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707568200 · Cited by 309
Hersh, E. M., O’Day, S. J., Powderly, J., Khan, K. D., Pavlick, A. C., Cranmer, L. D., Samlowski, W. E., Nichol, G. M., Yellin, M. J., & Weber, J. S. (2011) · Investigational New Drugs · doi:10.1007/s10637-009-9376-8 · Cited by 307
PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2
Zhang, F., Fan, Q., Ren, K., & Andreassen, P. R. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0123 · Cited by 306
Preventing Nonhomologous End Joining Suppresses DNA Repair Defects of Fanconi Anemia
Adamo, A., Collis, S. J., Adelman, C. A., Silva, N., Horejsi, Z., Ward, J. D., Martinez-Perez, E., Boulton, S. J., & La Volpe, A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.026 · Cited by 302
Repair tracts in mismatched DNA heteroduplexes.
Wagner, R., & Meselson, M. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.4135 · Cited by 301
Köberle, B., Masters, J. R. W., Hartley, J. A., & Wood, R. D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80118-3 · Cited by 300
DNA Damage Induced by Alkylating Agents and Repair Pathways
Kondo, N., Takahashi, A., Ono, K., & Ohnishi, T. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/543531 · Cited by 292
Genini, D., Adachi, S., Chao, Q., Rose, D. W., Carrera, C. J., Cottam, H. B., Carson, D. A., & Leoni, L. M. (2000) · Blood · doi:10.1182/blood.v96.10.3537 · Cited by 290
Brca2 is required for embryonic cellular proliferation in the mouse.
Suzuki, A., de la Pompa, J. L., Hakem, R., Elia, A., Yoshida, R., Mo, R., Nishina, H., Chuang, T., Wakeham, A., Itie, A., et al. (1997) · Genes & Development · doi:10.1101/gad.11.10.1242 · Cited by 287
Involvement of novel autophosphorylation sites in ATM activation
Kozlov, S. V., Graham, M. E., Peng, C., Chen, P., Robinson, P. J., & Lavin, M. F. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601231 · Cited by 283
Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells
Ferry, K. V., Hamilton, T. C., & Johnson, S. W. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00441-x · Cited by 275
Kratz, K., Schöpf, B., Kaden, S., Sendoel, A., Eberhard, R., Lademann, C., Cannavó, E., Sartori, A. A., Hengartner, M. O., & Jiricny, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.022 · Cited by 272
Thorslund, T., McIlwraith, M. J., Compton, S. A., Lekomtsev, S., Petronczki, M., Griffith, J. D., & West, S. C. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1905 · Cited by 262
Preclinical studies identifying carboplatin as a viable cisplatin alternative
Harrap, K. R. (1985) · Cancer Treatment Reviews · doi:10.1016/0305-7372(85)90015-5 · Cited by 259
Song, I.-S., Savaraj, N., Siddik, Z. H., Liu, P., Wei, Y., Wu, C. J., & Kuo, M. T. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1543.3.12 · Cited by 259
Discovery and development of clofarabine: a nucleoside analogue for treating cancer
Bonate, P. L., Arthaud, L., Cantrell, W. R., Stephenson, K., Secrist, J. A., & Weitman, S. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2055 · Cited by 257
Age to survive: DNA damage and aging
Schumacher, B., Garinis, G. A., & Hoeijmakers, J. H. J. (2008) · Trends in Genetics · doi:10.1016/j.tig.2007.11.004 · Cited by 254
Self-citationNucleoside analogs: molecular mechanisms signaling cell death
Ewald, B., Sampath, D., & Plunkett, W. (2008) · Oncogene · doi:10.1038/onc.2008.316 · Cited by 247
van der Pluijm, I., Garinis, G. A., Brandt, R. M. C., Gorgels, T. G. M. F., Wijnhoven, S. W., Diderich, K. E. M., de Wit, J., Mitchell, J. R., van Oostrom, C., Beems, R., et al. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0050002 · Cited by 240
Ku70 Corrupts DNA Repair in the Absence of the Fanconi Anemia Pathway
Pace, P., Mosedale, G., Hodskinson, M. R., Rosado, I. V., Sivasubramaniam, M., & Patel, K. J. (2010) · Science · doi:10.1126/science.1192277 · Cited by 239
The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs
Zhang, J., Visser, F., King, K. M., Baldwin, S. A., Young, J. D., & Cass, C. E. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9044-4 · Cited by 231
The Fanconi Anemia DNA Repair Pathway: Structural and Functional Insights into a Complex Disorder
Walden, H., & Deans, A. J. (2014) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-051013-022737 · Cited by 231
Drug transporters of platinum-based anticancer agents and their clinical significance
Burger, H., Loos, W. J., Eechoute, K., Verweij, J., Mathijssen, R. H. J., & Wiemer, E. A. C. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2010.12.002 · Cited by 230
On diseases of the skin, including the exanthemata
Hebra, F., Kaposi, M., Fagge, C. H., Pye-Smith, P. H., & Tay, W. K. (1866) · Medical Entomology and Zoology · Cited by 228
Recent Developments in the Field of Anticancer Platinum Complexes
Galanski, M. S. (2006) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489206777442287 · Cited by 223
Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines
Welsh, C., Day, R., McGurk, C., Masters, J. R. W., Wood, R. D., & Köberle, B. (2004) · International Journal of Cancer · doi:10.1002/ijc.20134 · Cited by 215
Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia
Sanger Mouse Genetics Project, Crossan, G. P., van der Weyden, L., Rosado, I. V., Langevin, F., Gaillard, P.-H. L., McIntyre, R. E., Gallagher, F., Kettunen, M. I., Lewis, D. Y., et al. (2011) · Nature Genetics · doi:10.1038/ng.752 · Cited by 211
ATM signaling and genomic stability in response to DNA damage
Lavin, M. F., Birrell, G., Chen, P., Kozlov, S., Scott, S., & Gueven, N. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.04.020 · Cited by 209
Huang, P., Chubb, S., & Plunkett, W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46267-3 · Cited by 206
Ye, Q., Hu, Y.-F., Zhong, H., Nye, A. C., Belmont, A. S., & Li, R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108049 · Cited by 206
Linking the Cellular Functions of BRCA Genes to Cancer Pathogenesis and Treatment
Venkitaraman, A. R. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.151422 · Cited by 203
Singh, T. R., Saro, D., Ali, A. M., Zheng, X.-F., Du, C.-H., Killen, M. W., Sachpatzidis, A., Wahengbam, K., Pierce, A. J., Xiong, Y., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.036 · Cited by 201
Stone, M. P., Cho, Y.-J., Huang, H., Kim, H.-Y., Kozekov, I. D., Kozekova, A., Wang, H., Minko, I. G., Lloyd, R. S., Harris, T. M., et al. (2008) · Accounts of Chemical Research · doi:10.1021/ar700246x · Cited by 187
Downregulation of XPF–ERCC1 enhances cisplatin efficacy in cancer cells☆
Arora, S., Kothandapani, A., Tillison, K., Kalman-Maltese, V., & Patrick, S. M. (2010) · DNA Repair · doi:10.1016/j.dnarep.2010.03.010 · Cited by 182
ATR activation and replication fork restart are defective in FANCM‐deficient cells
Schwab, R. A., Blackford, A. N., & Niedźwiedź, W. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.385 · Cited by 176
A Critical Appraisal of the Evolution of N-Nitrosoureas as Anticancer Drugs
Gnewuch, C. T., & Sosnovsky, G. (1997) · Chemical Reviews · doi:10.1021/cr941192h · Cited by 176
Role of the Copper Transporter, CTR1, in Platinum-Induced Ototoxicity
More, S. S., Akil, O., Ianculescu, A. G., Geier, E. G., Lustig, L. R., & Giacomini, K. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1544-10.2010 · Cited by 176
Hoeijmakers, J. H. J. (2001) · Maturitas · doi:10.1016/s0378-5122(00)00188-2 · Cited by 175
Regulation of endonuclease activity in human nucleotide excision repair
Fagbemi, A. F., Orelli, B., & Schärer, O. D. (2011) · DNA Repair · doi:10.1016/j.dnarep.2011.04.022 · Cited by 173
Immunoglobulin Class Switch Recombination Is Impaired in Atm-deficient Mice
Lumsden, J. M., McCarty, T., Petiniot, L. K., Shen, R., Barlow, C., Wynn, T. A., Morse, H. C., Gearhart, P. J., Wynshaw-Boris, A., Max, E. E., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041074 · Cited by 173
Nucleotide excision repair and cancer
Leibeling, D., Laspe, P., & Emmert, S. (2006) · Journal of Molecular Histology · doi:10.1007/s10735-006-9041-x · Cited by 164 · cited 2×
“A similar type of damage, as well resolved by NER, is caused by polycyclic aromatic hydrocarbons (tobacco smoke or DNA crosslinking agents like Cisplatin or Benzopyrene; Leibeling et al., 2006) and ROS-generated cyclopurines.”
BackgroundThe FHA and BRCT domains recognize ADP-ribosylation during DNA damage response
Li, M., Lu, L.-Y., Yang, C.-Y., Wang, S., & Yu, X. (2013) · Genes & Development · doi:10.1101/gad.226357.113 · Cited by 164
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
Cavanagh, H., & Rogers, K. (2015) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-015-0038-x · Cited by 163
PARP inhibitors: A new era of targeted therapy
Tangutoori, S., Baldwin, P., & Sridhar, S. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.01.015 · Cited by 152
Alkylating agents and cancer therapy
Ralhan, R., & Kaur, J. (2007) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.17.9.1061 · Cited by 147
Skp2 E3 Ligase Integrates ATM Activation and Homologous Recombination Repair by Ubiquitinating NBS1
Wu, J., Zhang, X., Zhang, L., Wu, C., Rezaeian, A. H., Chan, C., Li, J.-M., Wang, J., Gao, Y., Han, F., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.02.018 · Cited by 147
DNA mismatch repair and DNA methylation in adult brain neurons
Brooks, P. J., Marietta, C. A., & Goldman, D. A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-00939.1996 · Cited by 145
UV stalled replication forks restart by re-priming in human fibroblasts
Elvers, I., Johansson, F., Groth, P., Erixon, K., & Helleday, T. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr420 · Cited by 141
From old alkylating agents to new minor groove binders
Puyo, S., Montaudon, D., & Pourquier, P. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.07.006 · Cited by 139
Rosenberg, P. S., Tamary, H., & Alter, B. P. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34087 · Cited by 138
Targeting DNA repair mechanisms in cancer
Furgason, J. M., & Bahassi, E. M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.10.009 · Cited by 136
A comprehensive description of the severity groups in Cockayne syndrome
Natale, V. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33933 · Cited by 134
Functional Defects in the Fanconi Anemia Pathway in Pancreatic Cancer Cells
van der Heijden, M. S., Brody, J. R., Gallmeier, E., Cunningham, S. C., Dezentjé, D. A., Shen, D., Hruban, R. H., & Kern, S. E. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63329-9 · Cited by 129
Exploiting synthetic lethal interactions for targeted cancer therapy
Reinhardt, H. C., Jiang, H., Hemann, M. T., & Yaffe, M. B. (2009) · Cell Cycle · doi:10.4161/cc.8.19.9626 · Cited by 124
Kèlland, L. R. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.1009 · Cited by 124
Enhanced subunit interactions with gemcitabine-5′-diphosphate inhibit ribonucleotide reductases
Wang, J., Lohman, G. J. S., & Stubbe, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706803104 · Cited by 112
Zhang, J., Stevens, M. F. G., Laughton, C. A., Madhusudan, S., & Bradshaw, T. D. (2010) · Oncology · doi:10.1159/000306139 · Cited by 110
Bootsma, D., Kraemer, K., Claever, J., Hoeijmakers, J. H. J., Scriver, C. R., Beaudet, A. L., Sly, W. S., & Valle, D. L. (1997) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 110
McKay, B. C., Becerril, C., & Ljungman, M. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204901 · Cited by 109
The role of BRCA1 in DNA double-strand repair: Past and present
Caestecker, K. W., & Van de Walle, G. R. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.11.013 · Cited by 108 · cited 1×
“The critical link to its therapeutic potential became evident a few decades later when the secret load of the American vessel S.S. John Harvey was unleashed in the Italian harbor of Bari during a German air raid.”
BackgroundFitch, M. E., Cross, I. V., Turner, S. J., Adimoolam, S., Lin, C., Williams, K. G., & Ford, J. M. (2003) · DNA repair · doi:10.1016/s1568-7864(03)00066-1 · Cited by 104
BRCA1: exploring the links to transcription
Monteiro, Á. N. A. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01632-7 · Cited by 100
Cisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation
Damia, G. L. M., Filiberti, L., Vikhanskaya, F., Carrassa, L., Taya, Y., D’Incalci, M., & Broggini, M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900122 · Cited by 97
Genome-wide model for the normal eukaryotic DNA replication fork
Larrea, A. A., Lujan, S. A., McElhinny, S. A. N., Mieczkowski, P. A., Resnick, M. A., Gordenin, D. A., & Kunkel, T. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010178107 · Cited by 96
Moeller, B. J., Yordy, J. S., Williams, M. D., Giri, U. P., Raju, U., Molkentine, D. P., Byers, L. A., Heymach, J. V., Story, M. D., Lee, J. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2641 · Cited by 95
DNA Repair Targeting and Radiotherapy: A Focus on the Therapeutic Ratio
Thoms, J., & Bristow, R. G. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.06.003 · Cited by 93
Allen, C., Borak, T. B., Tsujii, H., & Nickoloff, J. A. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.02.012 · Cited by 92
Review of recent studies on resistance to cytotoxic deoxynucleoside analogues
Jordheim, L. P., & Dumontet, C. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.07.004 · Cited by 92
Premature aging and cancer in nucleotide excision repair-disorders
Diderich, K. E. M., Alanazi, M. A., & Hoeijmakers, J. H. J. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.04.025 · Cited by 90
Krasikova, Y. S., Rechkunova, N. I., Maltseva, E. A., Petruseva, I. O., & Lavrik, O. I. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq649 · Cited by 86
KRUMBHAAR, E. B., & Krumbhaar, H. D. (1919) · PubMed · Cited by 85
Defective homologous recombination in human cancers
Cerbinskaite, A., Mukhopadhyay, A., Plummer, E. R., Curtin, N. J., & Edmondson, R. J. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.04.015 · Cited by 85
Mismatch Repair Protein Deficiency Compromises Cisplatin-induced Apoptotic Signaling
Topping, R. P., Wilkinson, J. C., & Scarpinato, K. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809303200 · Cited by 82
Exploiting DNA mismatch repair deficiency as a therapeutic strategy
Guillotin, D., & Martin, S. A. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.07.004 · Cited by 78
Germline Mutation in ATR in Autosomal- Dominant Oropharyngeal Cancer Syndrome
Tanaka, A., Weinel, S., Nagy, N., O’Driscoll, M., Lai‐Cheong, J. E., Kulp‐Shorten, C. L., Knable, A. L., Carpenter, G., Fisher, S. A., Hiragun, M., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.01.007 · Cited by 78
Wilkinson, K. D., & Hochstrasser, M. (1998) · Springer eBooks · doi:10.1007/978-1-4899-1922-9_4 · Cited by 74
The Role of Membrane Transporters in Cellular Resistance to Anticancer Nucleoside Drugs
Clarke, M. L., Mackey, J. R., Baldwin, S. A., Young, J. D., & Cass, C. E. (2002) · Cancer treatment and research · doi:10.1007/978-1-4615-1173-1_2 · Cited by 65
Klapacz, J., Meira, L. B., Luchetti, D., Calvo, J. A., Bronson, R. T., Edelmann, W., & Samson, L. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811991106 · Cited by 64
Mechanisms of ATR-mediated checkpoint signalling
Smits, V. A. J. (2010) · Frontiers in bioscience · doi:10.2741/3649 · Cited by 53
Transcription-Coupled DNA Repair
Sweder, K., & Hanawalt, P. C. (1993) · Science · doi:10.1126/science.8211165 · Cited by 50
Loss ofCaenorhabditis elegansBRCA1 Promotes Genome Stability During Replication insmc-5Mutants
Wolters, S., Ermolaeva, M., Bickel, J. S., Fingerhut, J. M., Khanikar, J., Chan, R. C., & Schumacher, B. (2014) · Genetics · doi:10.1534/genetics.113.158295 · Cited by 32
Self-citationPaglia, L. L., Laugé, A., Weber, J., Champ, J., Cavaciuti, E., Russo, A. D., Viovy, J., & Stoppa‐Lyonnet, D. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0396-z · Cited by 28
Wang, Y., Liu, X., Matsuda, A., & Plunkett, W. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6885 · Cited by 23
Troxacitabine in acute leukemia
Swords, R. T., & Giles, F. J. (2007) · Hematology · doi:10.1080/10245330701406881 · Cited by 16
XPC (xeroderma pigmentosum, complementation group C)
Stary, A., & Sarasin, A. R. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/37724 · Cited by 8
Prestwich, E. G., & Dedon, P. C. (2009) · Wiley eBooks · doi:10.1002/9783527628100.ch1 · Cited by 5
Cited by
Gastric cancer: a comprehensive review of current and future treatment strategies
Sexton, R. E., Al Hallak, M. N., Diab, M., & Azmi, A. S. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09925-3 · Cited by 772
The challenge of drug resistance in cancer treatment: a current overview
Nikolaou, M., Pavlopoulou, A., Georgakilas, A. G., & Kyrodimos, E. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9903-0 · Cited by 600
Katerji, M., Filippova, M., & Duerksen-Hughes, P. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/1279250 · Cited by 429
DNA damage responses and p53 in the aging process
Ou, H.-L., & Schumacher, B. (2018) · Blood · doi:10.1182/blood-2017-07-746396 · Cited by 377
Self-citationTherapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review
Kamran, S., Sinniah, A., Abdulghani, M. A. M., & Alshawsh, M. A. (2022) · Cancers · doi:10.3390/cancers14051100 · Cited by 259
Metadata
- Authors
- Torgovnick, A., & Schumacher, B.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2015-04-23
- Volume
- 6
- Pages
- 157-157
- ISSN
- 1664-8021 (ISSN-L)
- OpenAlex
- W2073769648
- Cited by
- 396
- References
- 169
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.